menu search

Biocryst selects er-kim pharmaceuticals as commercial partner for orladeyo® (berotralstat) in turkey

RESEARCH TRIANGLE PARK, N.C., July 19, 2023 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the company has entered...

July 19, 2023, 11:00 am

Biocryst to present new orladeyo® (berotralstat) data at 2023 european academy of allergy and clinical immunology congress

RESEARCH TRIANGLE PARK, N.C., May 31, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals Inc (Nasdaq: BCRX) today announced that the company will prese...

May 31, 2023, 7:02 am

Biocryst to present new orladeyo® (berotralstat) data at 2022 american academy of allergy, asthma & immunology annual meeting

RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will pr...

February 1, 2022, 9:25 am

Biocryst to present new orladeyo® (berotralstat) data at 2022 american academy of allergy, asthma & immunology annual meeting

RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will pr...

February 1, 2022, 9:25 am

Biocryst to present new orladeyo® (berotralstat) data at 2022 american academy of allergy, asthma & immunology annual meeting

RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will pr...

February 1, 2022, 9:25 am


Search within

Pages Search Results: